US Broker Ratings

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unpacking a 201% Potential Upside for Patient Investors

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing the attention of investors intrigued by its promising growth prospects in the biotechnology sector. With a market cap of $531.78 million, this Carlsbad,..

InMode Ltd. (INMD) Stock Analysis: A Look at Potential Upside with Strong Return on Equity

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specializes in the medical devices industry, offering innovative minimally invasive aesthetic medical products. With its headquarters in Yokne’am, Israel,..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 12% Potential Upside for Investors

InnovAge Holding Corp. (NASDAQ: INNV) operates at the intersection of healthcare and elder care, serving the senior community with a comprehensive suite of medical and ancillary services. As the healthcare..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring a Potential 232.73% Upside Amidst Strong Analyst Confidence

For investors seeking opportunities in the biotech sector, Arcus Biosciences, Inc. (NASDAQ: RCUS) stands out with its significant potential upside and strong analyst support. Despite recent challenges, including a substantial..

AxoGen, Inc. (AXGN) Stock Analysis: Unveiling a Potential 122% Upside in the Medical Devices Sector

AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the medical devices industry, is making waves with its innovative approach to peripheral nerve regeneration. With a market capitalization of $497.8 million,..

Eton Pharmaceuticals, Inc. (ETON) Growth Potential: Rare Disease Focus with Over 105% Upside

Eton Pharmaceuticals, Inc. (ETON), a burgeoning entity in the healthcare sector, is making waves with its focus on developing and commercializing treatments for rare diseases. With its headquarters in Deer..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Unveiling a Potential 211% Upside in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) presents an intriguing opportunity for investors willing to navigate the high-risk, high-reward landscape of biotechnology stocks. With a current market cap of $312.44 million and..

HealthStream, Inc. (HSTM) Stock Analysis: Unpacking a 24.10% Potential Upside

HealthStream, Inc. (HSTM), a notable player in the healthcare information services sector, presents an intriguing investment opportunity for those looking to capitalize on technological advancements in healthcare. Headquartered in Nashville,..

Keros Therapeutics (KROS) Stock Analysis: Uncovering a 117% Potential Upside in Biotech

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with its innovative approach to treating disorders related to the transforming growth factor-beta family of..

AMN Healthcare Services Inc (AMN) Stock Analysis: Evaluating the 21% Potential Upside Amidst Market Challenges

AMN Healthcare Services Inc (NYSE: AMN) stands as a pivotal player within the healthcare sector, specifically in the medical care facilities industry. Based in Dallas, Texas, AMN provides a wide..

Immunome, Inc. (IMNM) Stock Analysis: Uncovering a Potential 177% Upside in Biotech

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology company, is capturing investor attention with its innovative approach to cancer treatment and a striking potential upside of 177.15%. As the healthcare sector..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 339% Potential Upside for Biotechnology Investors

For investors with an eye on the biotechnology sector, Kura Oncology, Inc. (NASDAQ: KURA) presents a compelling opportunity. Despite trading at $5.86, near the lower end of its 52-week range..

Community Health Systems, Inc. (CYH) Stock Analysis: Exploring a 23.59% Potential Upside

Community Health Systems, Inc. (NYSE: CYH) stands at the crossroads of opportunity and caution for investors looking to delve into the healthcare sector. With a market capitalization of around $478.44..

GH Research PLC (GHRS) Stock Analysis: Unpacking a 122% Potential Upside in the Biotech Sector

GH Research PLC (NASDAQ: GHRS), an innovative player in the biotechnology sector, is capturing investor attention with its robust potential upside of 122.21%. Based in Dublin, Ireland, this clinical-stage biopharmaceutical..

Akso Health Group (AHG) Stock Analysis: Navigating a 676% Revenue Growth Amidst Uncertain Valuations

Akso Health Group (AHG), a prominent player in China’s healthcare sector, is catching the eye of investors with its remarkable revenue growth of 676%. This substantial increase in revenue is..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: Unpacking a 241.70% Potential Upside in Brain Health Biotech

Mind Medicine (MindMed) Inc. (MNMD), a cutting-edge player in the biotechnology sector, is gaining significant attention from investors, largely due to its promising pipeline focused on brain health disorders. Headquartered..

CareDx, Inc. (CDNA) Stock Analysis: A 52% Upside Potential in the Diagnostics & Research Sector

CareDx, Inc. (CDNA), a prominent player within the healthcare sector, specifically in diagnostics and research, has caught the attention of investors with its innovative solutions for transplant patients. Headquartered in..

Weave Communications, Inc. (WEAV) Stock Analysis: Exploring a Potential 60.90% Upside in Healthcare Tech

Weave Communications, Inc. (NASDAQ: WEAV), a prominent player in the health information services industry, is making waves with its innovative software solutions designed for small to medium-sized healthcare businesses across..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unveiling a 511% Potential Upside Amidst Biotech Breakthroughs

Iovance Biotherapeutics, Inc. (IOVA) presents a compelling opportunity for investors in the healthcare sector, particularly those with an appetite for high-risk, high-reward ventures typical of the biotechnology industry. With a..

Syndax Pharmaceuticals (SNDX): Analyst Ratings Signal a Potential 279.80% Upside

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a prominent player in the biotechnology sector, is capturing significant attention from investors and analysts alike. With a market capitalization of $774.43 million, the company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds